acc1401 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
TF-1 |
KP372-1 |
Associated |
4.0 |
16585200
|
acc1402 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Lung Cancer |
NCI-H69 |
NNK |
Associated |
4.0 |
15210690
|
acc1403 |
c-Myc |
phosphorylation |
Thr58 |
human |
Lung Cancer |
NCI-H69 |
NNK |
Associated |
4.0 |
15210690
|
acc1404 |
c-Myc |
phosphorylation |
Thr58 |
human |
Lung Cancer |
NCI-H82 |
Staurosporine |
Associated |
4.0 |
15210690
|
acc1405 |
c-Myc |
phosphorylation |
Ser62 |
human |
Lung Cancer |
NCI-H82 |
Staurosporine |
Associated |
4.0 |
15210690
|
acc1406 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Lung Cancer |
NCI-H82 |
Staurosporine |
Associated |
4.0 |
15210690
|
acc1407 |
c-Myc |
phosphorylation |
Ser62 |
human |
Lung Cancer |
NCI-H69 |
NNK |
Associated |
4.0 |
15210690
|
acc1408 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Lung Cancer |
NCI-H82 |
NNK |
Associated |
4.0 |
15210690
|
acc1409 |
c-Myc |
phosphorylation |
Thr58 |
human |
Lung Cancer |
NCI-H82 |
NNK |
Associated |
4.0 |
15210690
|
acc1410 |
c-Myc |
phosphorylation |
Ser62 |
human |
Lung Cancer |
NCI-H82 |
NNK |
Associated |
4.0 |
15210690
|
acc1411 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Lung Cancer |
NCI-H82 |
Cisplatin |
Impairing |
5.0 |
15210690
|
acc1412 |
c-Myc |
phosphorylation |
Thr58 |
human |
Lung Cancer |
NCI-H82 |
PD98059 |
Associated |
4.0 |
15210690
|
acc1413 |
c-Myc |
phosphorylation |
Ser62 |
human |
Lung Cancer |
NCI-H82 |
PD98059 |
Associated |
4.0 |
15210690
|
acc1414 |
Bcl-2 |
phosphorylation |
Ser70 |
human |
Lung Cancer |
NCI-H82 |
PD98059 |
Associated |
4.0 |
15210690
|
acc1415 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
H2286 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1416 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
H2286 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1417 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H2286 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1418 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
HCC366 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1419 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
H2286 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1420 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
H2286 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1421 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
HCC366 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1422 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
HCC366 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1423 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
HCC366 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1424 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
HCC366 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1425 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
H2286 |
Dasatinib + Crizotinib |
Associated |
4.0 |
25348954
|
acc1426 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
HCC366 |
Dasatinib + BMS-754807 |
Associated |
4.0 |
25348954
|
acc1427 |
HSP27 |
phosphorylation |
Ser82 |
human |
Lung Cancer |
A549 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1428 |
eIF2a |
phosphorylation |
Ser51 |
human |
Lung Cancer |
A549 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1429 |
IRS1 |
phosphorylation |
Ser1101 |
human |
Lung Cancer |
A549 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1430 |
HSP27 |
phosphorylation |
Ser82 |
human |
Lung Cancer |
H1299 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1431 |
eIF2a |
phosphorylation |
Ser51 |
human |
Lung Cancer |
H1299 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1432 |
IRS1 |
phosphorylation |
Ser1101 |
human |
Lung Cancer |
H1299 |
ZNF323A OE |
Associated |
3.0 |
32576196
|
acc1433 |
Akt |
phosphorylation |
Ser473 |
mouse |
Leukemia |
DA1-3b/d365 |
Imatinib |
Impairing |
5.0 |
21804606
|
acc1434 |
Akt |
phosphorylation |
Ser473 |
mouse |
Leukemia |
DA1-3b/M1 |
Imatinib |
Impairing |
5.0 |
21804606
|
acc1435 |
Akt |
phosphorylation |
Ser473 |
mouse |
Leukemia |
DA1-3b/M2 |
Imatinib |
Impairing |
5.0 |
21804606
|
acc1436 |
Akt |
phosphorylation |
Ser473 |
mouse |
Leukemia |
DA1-3b/M2 |
Staurosporine |
Impairing |
5.0 |
21804606
|
acc1437 |
AKT |
phosphorylation |
Ser473 |
human |
Leukemia |
K562-r |
Imatinib |
Impairing |
5.0 |
21804606
|
acc1438 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
|
Rapamycin |
Associated |
4.0 |
23874880
|
acc1439 |
p70S6K |
phosphorylation |
Ser371 |
human |
Lung Cancer |
|
Ku0063794 |
Enhancing |
5.0 |
23874880
|
acc1440 |
mTOR |
phosphorylation |
Ser2448 |
rat |
Glioma |
C6 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1441 |
Akt |
phosphorylation |
Ser473 |
rat |
Glioma |
C6 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1442 |
ULK1 |
phosphorylation |
Ser467 |
rat |
Glioma |
C6 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1443 |
mTOR |
phosphorylation |
Ser2448 |
human |
Glioma |
U251 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1444 |
AKT |
phosphorylation |
Ser473 |
human |
Glioma |
U251 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1445 |
ULK1 |
phosphorylation |
Ser467 |
human |
Glioma |
U251 |
Xanthatin |
Associated |
4.0 |
36572650
|
acc1446 |
p38 |
phosphorylation |
Tyr182 |
human |
Hepatocellular Carcinoma |
SMMC-7721 |
mAb AA98 |
Associated |
4.0 |
17121934
|
acc1447 |
p53 |
phosphorylation |
Ser15 |
human |
Melanoma |
A375 |
"3,3'-diselenodipropionic acid (DSeA)" |
Associated |
4.0 |
25277183
|
acc1448 |
p53 |
phosphorylation |
Ser15 |
human |
Melanoma |
A375 |
TRAIL |
Enhancing |
5.0 |
25277183
|
acc1449 |
AKT |
phosphorylation |
Thr308 |
human |
Melanoma |
A375 |
"3,3'-diselenodipropionic acid (DSeA)" |
Associated |
4.0 |
25277183
|
acc1450 |
AKT |
phosphorylation |
Thr308 |
human |
Melanoma |
A375 |
TRAIL |
Impairing |
5.0 |
25277183
|